Mark Zitter, Founder and CEO of The Zitter Group, in San Francisco and Millburn, NJ, and Chairman of Vital Decisions, talks about the company's telephone counseling service aimed lowering costs by assisting end-of-life oncology patients with making informed decisions about their care.
Mr. Zitter also discusses how Vital Decisions works with private and government payers, in addition to terminal cancer patients, with the overarching goal of eliminating unnecessary costs and care that these patients may not want or need. Once a patient reaches a final decision, the company assists with communicating the patient's wishes to their family and medical team.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More